Go to Wolters Kluwer VitalLaw.comGo to Wolters Kluwer VitalLaw.com
VitalLaw®
  • Find answers to your questions
  • Log in to access your subscriptions
In depth. On point.
In depth. On point.
  • Home
  • Legal Directory
  • Home
  • Legal Directory
In depth. On point.
  • Articles
    • Articles
  • Law Firms
    • Law Firms
  • Organizations
    • Organizations
    • TOBACCO—S.D.W. Va.: Preliminary injunction issued over West Virginia vaping law
    • ADVERTISING (FOOD, DRUG & MEDICAL DEVICES)—E.D.N.Y.: Misleading advertising class action involving ‘all natural’ beverage claims can’t hold water
    • ANTI-KICKBACK PROHIBITION—D.C. Cir.: Fertility-preservation payments tied to gene therapy violate anti-kickback law
    • CONDITIONS OF PARTICIPATION—DAB DECISIONS: Second application sets Medicare billing clock
    • CONTROLLED SUBSTANCES—NOTICES: Stephen Bossenberry, M.D.; Decision and Order
    • GENERAL HEALTH CARE NEWS—PROPOSED RULES: HHS proposes consolidation, redesignation of repatriation of mentally ill nationals regulations
    • HEALTH CARE REFORM—11th Cir.: Vacatur of HHS gender-identity provisions moots Florida challenge
    • LABELING AND PACKAGING (FOOD, DRUGS & MEDICAL DEVICES)—N.D. Ill: Court dismisses false advertising action involving allegedly ineffective wellness shots
    • PRESCRIPTION DRUGS—2d Cir.: District court erred in ordering remand based on disclaimers of federal conduct claims
    • PRODUCTS LIABILITY (DEVICES)—9th Cir.: Woman’s arguments fail to prove that her complaint against IVC filter makers was timely filed
  • Articles
    • Articles
  • Law Firms
    • Law Firms
  • Organizations
    • Organizations

    Health Law Daily Wrap Up, CONTROLLED SUBSTANCES—NOTICES: Stephen Bossenberry, M.D.; Decision and Order, (Sep 10, 2026)

    By WK Editorial Staff

    The registrant did not request a hearing, and the DEA found him to be in default.

    On February 18, 2026, the Drug Enforcement Administration (DEA) issued an Order to Show Cause (OSC) to Stephen Bossenberry, M.D., of Grand Blanc, Michigan (Registrant). ...

    By WK Editorial Staff

    The registrant did not request a hearing, and the DEA found him to be in default.

    On February 18, 2026, the Drug Enforcement Administration (DEA) issued an Order to Show Cause (OSC) to Stephen Bossenberry, M.D., of Grand Blanc, Michigan (Registrant). The OSC proposed the revocation of the registrant’s Certificate of Registration No. FB7239393, alleging that the registrant’s registration should be revoked because the registrant is “currently without authority to prescribe, administer, dispense, or otherwise handle controlled substances in the State of Michigan, the state in which [he is] registered with DEA.” (citing 21 U.S.C. 824(a)(3)). Because the registrant lacks authority to handle controlled substances in Michigan, the registrant is not eligible to maintain a DEA registration. Accordingly, the DEA ordered that the registrant’s DEA registration be revoked (Notice, 91 Fed. Reg. 57163 (Sept. 8, 2026)).

    Dates. The order is effective October 8, 2026.

    FederalRegisterIssuances: Notices ControlledNews GeneralNews

    © 2026 CCH Incorporated and its affiliates and licensors. All rights reserved.

    • Manage Cookie Preferences
    • Privacy Statement
    • Terms of Use